OXYS: Gaining Momentum with Revenue Growth in 2Q 2015

OxySure sold $2.7 million in convertible preferred stock and $300,000 in two convertible notes, totaling $3 million. OxySure received net proceeds comprising a first tranche of $1 million in part from the issuance of 385,000 shares of newly created Series C convertible preferred stock with a stated value of $2.00 per share in cash at the closing on June 30, 2015. A second tranche, comprised of …

Read more